Search - tctmd.com

Displaying 401 - 420 of 562

Sort: Relevancy | Date

Presentation ISET 2016

Drug-Coated Balloons in the SFA: A Class of Devices with Differentiated Outcomes?

Presenter: Thomas Zeller

February 07, 2016

Presentation ISET 2016

Drug-Coated Balloons in the Venous Circulation: Is There a Place?

Presenter: Constantino Pe?a

February 05, 2016

News Industry News

Positive Six-Month Tack Optimized Balloon Angioplasty Below-the-Knee (TOBA-BTK) Results Presented at LINC 2016

January 25, 2016

News Industry News

QT Vascular Announces Clinical Outcomes of Its Chocolate Heart Drug Coated Coronary Balloon

January 06, 2016

News Daily News

Atherectomy Plus Angioplasty Reduces Mortality, Amputation Risk But Adds Hefty Initial Price

Yael L. Maxwell

December 13, 2015

Presentation

Effect of Drug-Coated Balloons (DCBs) inNative CAD Left With a Dissection

Presenter: Bernardo Cortese

November 29, 2015

News Daily News

Residual Dissection After DCB Treatment for De Novo CAD Generally Resolves

Caitlin E. Cox

November 26, 2015

News Conference News VEITH 2015

DCBs for Femoropoliteal Disease: What’s Now and What’s Next?

Yael L. Maxwell

November 19, 2015

News Daily News

More Discouraging News for DCBs in Treatment of Infrapopliteal Lesions

L.A. McKeown

October 26, 2015

News Industry News

Plaque Modification With Scoring Balloon Improves Angiographic Outcomes In Patients Treated With A Drug-Coated Balloon For Drug-Eluting Stent Restenosis

October 14, 2015

News Industry News

Drug-Coated Balloon Shown To Be Superior To Conventional Angioplasty In Treating Superficial Femoral Artery Disease After Two Years

October 14, 2015

Presentation TCT 2015

The Technological Evolution of Local Drug Delivery: Implications for the Clinical Adoption of Coronary DCBs

Presenter: Juan F. Granada, Bruno Scheller

October 13, 2015

Presentation TCT 2015

Life After the RIBS Trials: A Critical Overview of the Data and Implications for Clinical Practice

Presenter: Juan F. Granada, Bruno Scheller, Fernando Alfonso

October 13, 2015

Presentation TCT 2015

DCB for ISR Treatment: Technical Considerations for Optimization of Clinical Outcomes

Presenter: Juan F. Granada, Bruno Scheller, Pieter R. Stella

October 13, 2015

Presentation TCT 2015

The Promise of Vascular Restoration Therapy for De Novo Lesions: Technique, Limitations, and Clinical Data

Presenter: Juan F. Granada, Bruno Scheller

October 13, 2015

Presentation TCT 2015

Clinical Trial Debate: Do DCBs Work for the BTK Indication? No, DCBs Will Never Work in BTK Arteries!

Presenter: Gary M. Ansel, J. A. Mustapha, Ron Waksman

October 12, 2015

Presentation TCT 2015

Clinical Trial Debate: Do DCBs Work for the BTK Indication? Yes, Perform DCB Angioplasty of BTK Lesions Correctly and They Work!

Presenter: Gary M. Ansel, J. A. Mustapha, Francesco Liistro

October 12, 2015

Presentation TCT 2015

After 2 Failed RCTs: Root-Cause Analysis, Unmet Technical Needs and Opportunities for the Development of Next-Generation DCBs, and Studies

Presenter: Gary M. Ansel, J. A. Mustapha

October 12, 2015

Presentation TCT 2015

DCB in BTK Intervention: Summary of the Evidence From 2 Failed RCTs IN.PACT DEEP and BIOLUX P-II

Presenter: Gary M. Ansel, J. A. Mustapha

October 12, 2015

Presentation TCT 2015

BTK Disease: Impact of Disease Complexity on Technical Approach and Clinical Outcomes Are DCBs the Right Answer?

Presenter: Gary M. Ansel, J. A. Mustapha, Peter A. Schneider

October 12, 2015

Advertisement

Drug-Coated Balloons in the SFA: A Class of Devices with Differentiated Outcomes?

Drug-Coated Balloons in the Venous Circulation: Is There a Place?

Positive Six-Month Tack Optimized Balloon Angioplasty Below-the-Knee (TOBA-BTK) Results Presented at LINC 2016

QT Vascular Announces Clinical Outcomes of Its Chocolate Heart Drug Coated Coronary Balloon

Atherectomy Plus Angioplasty Reduces Mortality, Amputation Risk But Adds Hefty Initial Price

Effect of Drug-Coated Balloons (DCBs) inNative CAD Left With a Dissection

Residual Dissection After DCB Treatment for De Novo CAD Generally Resolves

DCBs for Femoropoliteal Disease: What’s Now and What’s Next?

More Discouraging News for DCBs in Treatment of Infrapopliteal Lesions

Plaque Modification With Scoring Balloon Improves Angiographic Outcomes In Patients Treated With A Drug-Coated Balloon For Drug-Eluting Stent Restenosis

Drug-Coated Balloon Shown To Be Superior To Conventional Angioplasty In Treating Superficial Femoral Artery Disease After Two Years

The Technological Evolution of Local Drug Delivery: Implications for the Clinical Adoption of Coronary DCBs

Life After the RIBS Trials: A Critical Overview of the Data and Implications for Clinical Practice

DCB for ISR Treatment: Technical Considerations for Optimization of Clinical Outcomes

The Promise of Vascular Restoration Therapy for De Novo Lesions: Technique, Limitations, and Clinical Data

Clinical Trial Debate: Do DCBs Work for the BTK Indication? No, DCBs Will Never Work in BTK Arteries!

Clinical Trial Debate: Do DCBs Work for the BTK Indication? Yes, Perform DCB Angioplasty of BTK Lesions Correctly and They Work!

After 2 Failed RCTs: Root-Cause Analysis, Unmet Technical Needs and Opportunities for the Development of Next-Generation DCBs, and Studies

DCB in BTK Intervention: Summary of the Evidence From 2 Failed RCTs IN.PACT DEEP and BIOLUX P-II

BTK Disease: Impact of Disease Complexity on Technical Approach and Clinical Outcomes Are DCBs the Right Answer?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content